Pfizer
PFE
2,915 hedge funds and large institutions have $108B invested in Pfizer in 2026 Q3 according to their latest regulatory filings, with 258 funds opening new positions, 1,154 increasing their positions, 1,218 reducing their positions, and 133 closing their positions.
94% more first-time investments, than exits
New positions opened: 258 | Existing positions closed: 133
62% more funds holding in top 10
Funds holding in top 10: 21 → 34 (+13)
16% more call options, than puts
Call options by funds: $3.11B | Put options by funds: $2.68B
2% more funds holding
Funds holding: 2,864 → 2,915 (+51)
5% less repeat investments, than reductions
Existing positions increased: 1,154 | Existing positions reduced: 1,218
1.39% less ownership
Funds ownership: 67.54% → 66.15% (-1.4%)
12% less capital inflows, than outflows
Capital inflows: $5.83B | Capital outflows: $6.63B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$759M |
| 2 |
Amundi
Paris,
France
|
+$356M |
| 3 |
D.E. Shaw & Co
New York
|
+$297M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$214M |
| 5 |
Two Sigma Investments
New York
|
+$162M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$951M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$441M |
| 3 |
Bank of New York Mellon
New York
|
-$332M |
| 4 |
Goldman Sachs
New York
|
-$244M |
| 5 |
BlackRock
New York
|
-$230M |
PFE Hedge Fund Activity: Q3 2026 in Review
2,915 of the 8,220 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q3 2026, worth a combined $108B — up 16% from $92.7B a quarter earlier.
Buyers outnumbered sellers: 258 funds opened new PFE positions and 133 closed out — a net gain of 125 holders — while 1,154 added to existing stakes and 1,218 trimmed.
The largest buyer was AQR Capital Management, adding an estimated $759M. The largest seller was Royal Bank of Canada, cutting an estimated $951M.
- 2,915 institutional investors held Pfizer (PFE) as of Q3 2026, up from 2,864 in Q2 2026.
- Funds reported $108B of Pfizer stock for Q3 2026, up 16% quarter-over-quarter.
- 258 funds opened new Pfizer positions in Q3 2026 and 133 closed out, a net change of +125 holders.
- The largest Pfizer buyer in Q3 2026 was AQR Capital Management, an estimated $759M added.
- The largest Pfizer seller in Q3 2026 was Royal Bank of Canada, an estimated $951M sold.
Based on aggregated 13F filings for Q3 2026.